Your browser doesn't support javascript.
loading
Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt.
Sevilla, J P; Burnes, Daria; El Saie, Rehab Zakaria; Haridy, Hammam; Wasserman, Matt; Pugh, Sarah; Perdrizet, Johnna; Bloom, David.
Afiliação
  • Sevilla JP; Life Sciences Group, Data for Decisions LLC, Waltham, MA, USA.
  • Burnes D; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • El Saie RZ; Life Sciences Group, Data for Decisions LLC, Waltham, MA, USA.
  • Haridy H; Medical Department, Pfizer, Cairo, Egypt.
  • Wasserman M; Medical & Scientific Affairs EM-AfME, Pfizer Gulf, Dubai, United Arab Emirates.
  • Pugh S; Health Economics and Outcomes Research, Pfizer Inc, New York City, NY, USA.
  • Perdrizet J; Medical and Scientific Affairs, Pfizer Inc, Collegeville, PA, USA.
  • Bloom D; Health Economics and Outcomes Research, Pfizer Inc, New York City, NY, USA.
Hum Vaccin Immunother ; 18(6): 2114252, 2022 Nov 30.
Article em En | MEDLINE | ID: mdl-36070504
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Idioma: En Ano de publicação: 2022 Tipo de documento: Article